AIRLINK 80.60 Increased By ▲ 1.19 (1.5%)
BOP 5.26 Decreased By ▼ -0.07 (-1.31%)
CNERGY 4.52 Increased By ▲ 0.14 (3.2%)
DFML 34.50 Increased By ▲ 1.31 (3.95%)
DGKC 78.90 Increased By ▲ 2.03 (2.64%)
FCCL 20.85 Increased By ▲ 0.32 (1.56%)
FFBL 33.78 Increased By ▲ 2.38 (7.58%)
FFL 9.70 Decreased By ▼ -0.15 (-1.52%)
GGL 10.11 Decreased By ▼ -0.14 (-1.37%)
HBL 117.85 Decreased By ▼ -0.08 (-0.07%)
HUBC 137.80 Increased By ▲ 3.70 (2.76%)
HUMNL 7.05 Increased By ▲ 0.05 (0.71%)
KEL 4.59 Decreased By ▼ -0.08 (-1.71%)
KOSM 4.56 Decreased By ▼ -0.18 (-3.8%)
MLCF 37.80 Increased By ▲ 0.36 (0.96%)
OGDC 137.20 Increased By ▲ 0.50 (0.37%)
PAEL 22.80 Decreased By ▼ -0.35 (-1.51%)
PIAA 26.57 Increased By ▲ 0.02 (0.08%)
PIBTL 6.76 Decreased By ▼ -0.24 (-3.43%)
PPL 114.30 Increased By ▲ 0.55 (0.48%)
PRL 27.33 Decreased By ▼ -0.19 (-0.69%)
PTC 14.59 Decreased By ▼ -0.16 (-1.08%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.75 Decreased By ▼ -0.75 (-1.11%)
SSGC 11.00 Decreased By ▼ -0.09 (-0.81%)
TELE 9.11 Decreased By ▼ -0.12 (-1.3%)
TPLP 11.46 Decreased By ▼ -0.10 (-0.87%)
TRG 70.23 Decreased By ▼ -1.87 (-2.59%)
UNITY 25.20 Increased By ▲ 0.38 (1.53%)
WTL 1.33 Decreased By ▼ -0.07 (-5%)
BR100 7,626 Increased By 100.3 (1.33%)
BR30 24,814 Increased By 164.5 (0.67%)
KSE100 72,743 Increased By 771.4 (1.07%)
KSE30 24,034 Increased By 284.8 (1.2%)

imageTOKYO: Some of Japan's top scientists have been unable to reproduce results of what was once billed as a ground-breaking stem cell study, but which spiralled into a scandal that included a respected researcher's suicide, reports said Thursday.

The government-backed Riken Institute will announce Friday that so-called "STAP" cells cannot be reproduced, writing the embarrassing final chapter of a study published in the journal Nature but later withdrawn, according to national broadcaster NHK.

"Cells with pluripotency could not be created under the method spelled out in the study," NHK said, citing unnamed sources.

Riken in January trumpeted how Haruko Obokata, now 31, had devised a simple method to re-programme adult cells to work like stem cells -- the precursors that are capable of developing into any other cell in the human body.

The study was top news in Japan, where the photogenic Obokata, a Harvard-trained scientist, became a phenomenon.

But media attention soon grew into scepticism as doubts emerged about Obokata's papers on Stimulus-Triggered Acquisition of Pluripotency (STAP).

Mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists.

Obokata, who asserted that she created STAP cells some 200 times, since July has been trying in tandem with independent teams to reproduce her own results.

She claimed there was a secret knack for creating STAP cells, but has refused to publicise it, asserting it is a subject of her future papers.

Leading science journal Nature withdrew the flawed study after Obokata agreed in June to retract the papers.

As the scandal deepened, Obokata's mentor and co-author, stem cell scientist Yoshiki Sasai, hanged himself, further shaking Japan's scientific establishment.

Riken has pledged to restructure its Center for Developmental Biology where the scandal took place.

Copyright AFP (Agence France-Presse), 2014

Comments

Comments are closed.